Insider Transactions in Q3 2023 at Corcept Therapeutics Inc (CORT)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 19
2023
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,000
-18.52%
|
$160,000
$32.74 P/Share
|
Sep 19
2023
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
25,000
-25.35%
|
$800,000
$32.48 P/Share
|
Sep 18
2023
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+20.22%
|
$75,000
$3.02 P/Share
|
Sep 14
2023
|
Gary Charles Robb Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,996
-22.85%
|
$263,868
$33.8 P/Share
|
Sep 14
2023
|
Gary Charles Robb Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,963
+28.52%
|
$41,889
$3.29 P/Share
|
Sep 05
2023
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$70,400
$32.9 P/Share
|
Sep 05
2023
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$11,000
$5.86 P/Share
|
Sep 01
2023
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
1,550
-100.0%
|
$49,600
$32.73 P/Share
|
Sep 01
2023
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
1,550
+50.0%
|
$9,300
$6.55 P/Share
|
Sep 01
2023
|
Atabak Mokari Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
796
+4.74%
|
$12,736
$16.55 P/Share
|
Sep 01
2023
|
Joseph Douglas Lyon |
BUY
Grant, award, or other acquisition
|
Direct |
722
+5.99%
|
$11,552
$16.55 P/Share
|
Sep 01
2023
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
5,000
-49.35%
|
$160,000
$32.73 P/Share
|
Sep 01
2023
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+33.04%
|
$55,000
$11.35 P/Share
|
Sep 01
2023
|
Gary Charles Robb Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+2.35%
|
$16,000
$16.55 P/Share
|
Sep 01
2023
|
Sean Maduck |
BUY
Grant, award, or other acquisition
|
Direct |
912
+0.62%
|
$14,592
$16.55 P/Share
|
Sep 01
2023
|
William Guyer Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
956
+8.0%
|
$15,296
$16.55 P/Share
|
Aug 29
2023
|
David L Mahoney |
BUY
Bona fide gift
|
Indirect |
34,850
+43.03%
|
-
|
Aug 29
2023
|
David L Mahoney |
SELL
Bona fide gift
|
Indirect |
52,270
-2.16%
|
-
|
Aug 21
2023
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
4,588
-47.2%
|
$142,228
$31.19 P/Share
|
Aug 21
2023
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
4,588
+18.8%
|
$41,292
$9.81 P/Share
|
Aug 14
2023
|
David L Mahoney |
SELL
Open market or private sale
|
Indirect |
25,000
-24.08%
|
$750,000
$30.95 P/Share
|
Aug 14
2023
|
Hazel Hunt Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,455
-21.85%
|
$613,650
$30.89 P/Share
|
Aug 08
2023
|
Hazel Hunt Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
29,545
-23.99%
|
$886,350
$30.48 P/Share
|
Aug 08
2023
|
Hazel Hunt Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+28.88%
|
$150,000
$3.02 P/Share
|
Aug 07
2023
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
412
+7.43%
|
$3,296
$8.27 P/Share
|
Aug 07
2023
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
412
-8.03%
|
$12,772
$31.22 P/Share
|
Aug 07
2023
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,850
-88.6%
|
$85,500
$30.15 P/Share
|
Aug 07
2023
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,850
+34.29%
|
$17,100
$6.21 P/Share
|
Jul 17
2023
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.09%
|
$10,000
$1.92 P/Share
|
Jul 17
2023
|
G Leonard Baker Jr Director |
SELL
Bona fide gift
|
Indirect |
0
|
-
|